We found that loss of Snord67 leads to changes in the splicing landscape of both murine and human breast cancer cells (Figs. 6, 7), resulting in differential alternative splicing of cassette exons as well as decreased overall intron retention. This evidence concerns the gene SNORD67 and breast carcinoma.